Cerebrospinal Fluid

Cerebrospinal fluid (CSF) plays a crucial role in Alzheimer's Disease (AD) and dementia research. In AD, abnormal accumulation of proteins like amyloid-beta and tau in the brain leads to cognitive decline. CSF acts as a conduit for these biomarkers, reflecting changes in their levels. Researchers use CSF analysis to detect early signs of AD by measuring amyloid-beta and tau proteins. Elevated levels of tau and decreased amyloid-beta in CSF are indicative of neurodegeneration and correlate with cognitive impairment. This fluid also helps in drug development, as changes in biomarkers can indicate treatment effectiveness. Understanding CSF dynamics enhances diagnostic accuracy and provides insights into disease progression, offering hope for earlier interventions and improved management strategies for AD and related dementias.